141 related articles for article (PubMed ID: 33588415)
1. Soluble Epoxide Hydrolase as an Important Player in Intestinal Cell Differentiation.
Cizkova K; Koubova K; Foltynkova T; Jiravova J; Tauber Z
Cells Tissues Organs; 2020; 209(4-6):177-188. PubMed ID: 33588415
[TBL] [Abstract][Full Text] [Related]
2. HT-29 and Caco2 Cell Lines Are Suitable Models for Studying the Role of Arachidonic Acid-Metabolizing Enzymes in Intestinal Cell Differentiation.
Cizkova K; Birke P; Malohlava J; Tauber Z; Huskova Z; Ehrmann J
Cells Tissues Organs; 2019; 208(1-2):37-47. PubMed ID: 32248197
[TBL] [Abstract][Full Text] [Related]
3. PTEN and soluble epoxide hydrolase in intestinal cell differentiation.
Koubova K; Cizkova K; Burianova A; Tauber Z
Biochim Biophys Acta Gen Subj; 2023 Dec; 1867(12):130496. PubMed ID: 37866587
[TBL] [Abstract][Full Text] [Related]
4. Time-dependent expression pattern of cytochrome P450 epoxygenases and soluble epoxide hydrolase in normal human placenta.
Cizkova K; Tauber Z
Acta Histochem; 2018 Aug; 120(6):513-519. PubMed ID: 29908721
[TBL] [Abstract][Full Text] [Related]
5. Expression of cytochrome P450 epoxygenases and soluble epoxide hydrolase is regulated by hypolipidemic drugs in dose-dependent manner.
Cizkova K
Toxicol Appl Pharmacol; 2018 Sep; 355():156-163. PubMed ID: 29960002
[TBL] [Abstract][Full Text] [Related]
6. Increased epoxyeicosatrienoic acids may be part of a protective mechanism in human ulcerative colitis, with increased CYP2J2 and reduced soluble epoxide hydrolase expression.
Qiu YE; Qin J; Luo Y; Qin SL; Mu YF; Cun R; Jiang HL; Chen JJ; Yu MH; Zhong M
Prostaglandins Other Lipid Mediat; 2018 May; 136():9-14. PubMed ID: 29580941
[TBL] [Abstract][Full Text] [Related]
7. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
Xu X; Zhang XA; Wang DW
Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627
[TBL] [Abstract][Full Text] [Related]
8. Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer.
Wei X; Zhang D; Dou X; Niu N; Huang W; Bai J; Zhang G
BMC Cancer; 2014 Nov; 14():841. PubMed ID: 25406731
[TBL] [Abstract][Full Text] [Related]
9. Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta.
Dalle Vedove F; Fava C; Jiang H; Zanconato G; Quilley J; Brunelli M; Guglielmi V; Vattemi G; Minuz P
J Hypertens; 2016 Jul; 34(7):1364-70. PubMed ID: 27115337
[TBL] [Abstract][Full Text] [Related]
10. Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice.
Zhou Y; Yang J; Sun GY; Liu T; Duan JX; Zhou HF; Lee KS; Hammock BD; Fang X; Jiang JX; Guan CX
Cell Tissue Res; 2016 Feb; 363(2):399-409. PubMed ID: 26310139
[TBL] [Abstract][Full Text] [Related]
11. Soluble Epoxide Hydrolase as a Potential Key Factor for Human Prenatal Development.
Cizkova K; Rajdova A; Ehrmann J
Cells Tissues Organs; 2016; 201(4):277-86. PubMed ID: 27144772
[TBL] [Abstract][Full Text] [Related]
12. Fibrates Affect Levels of Phosphorylated p38 in Intestinal Cells in a Differentiation-Dependent Manner.
Cizkova K; Tauber Z
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175404
[TBL] [Abstract][Full Text] [Related]
13. Soluble epoxide hydrolase: a novel target for the treatment of hypertension.
Fang X
Recent Pat Cardiovasc Drug Discov; 2006 Jan; 1(1):67-72. PubMed ID: 18221075
[TBL] [Abstract][Full Text] [Related]
14. Role of epoxyeicosatrienoic acids in cardiovascular diseases and cardiotoxicity of drugs.
Zhang Y; Gao L; Yao B; Huang S; Zhang Y; Liu J; Liu Z; Wang X
Life Sci; 2022 Dec; 310():121122. PubMed ID: 36309225
[TBL] [Abstract][Full Text] [Related]
15. Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration.
Wang Q; Huo L; He J; Ding W; Su H; Tian D; Welch C; Hammock BD; Ai D; Zhu Y
Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1894-903. PubMed ID: 26453326
[TBL] [Abstract][Full Text] [Related]
16. Beyond detoxification: a role for mouse mEH in the hepatic metabolism of endogenous lipids.
Marowsky A; Meyer I; Erismann-Ebner K; Pellegrini G; Mule N; Arand M
Arch Toxicol; 2017 Nov; 91(11):3571-3585. PubMed ID: 28975360
[TBL] [Abstract][Full Text] [Related]
17. Acute mercury toxicity modulates cytochrome P450, soluble epoxide hydrolase and their associated arachidonic acid metabolites in C57Bl/6 mouse heart.
Amara IE; Elshenawy OH; Abdelrady M; El-Kadi AO
Toxicol Lett; 2014 Apr; 226(1):53-62. PubMed ID: 24472606
[TBL] [Abstract][Full Text] [Related]
18. Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE₂ induced pain model.
Goswami SK; Inceoglu B; Yang J; Wan D; Kodani SD; da Silva CA; Morisseau C; Hammock BD
Toxicol Appl Pharmacol; 2015 Dec; 289(3):419-27. PubMed ID: 26522832
[TBL] [Abstract][Full Text] [Related]
19. Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure.
Sun D; Cuevas AJ; Gotlinger K; Hwang SH; Hammock BD; Schwartzman ML; Huang A
Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1146-53. PubMed ID: 24561863
[TBL] [Abstract][Full Text] [Related]
20. [Soluble epoxide hydrolase and lipid metabolism].
Ma XX; Liu Y; Zhu Y
Sheng Li Ke Xue Jin Zhan; 2010 Aug; 41(4):267-71. PubMed ID: 21416942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]